Exposure to Plastics Chemical BPA May Raise Diabetes Risk

Follow Drugslib on

Medically reviewed by Drugs.com.

By Dennis Thompson HealthDay Reporter

WEDNESDAY, June 26, 2024 -- A common plastics chemical might increase a person’s risk of diabetes, a new study warns.

People fed small doses of Bisphonol A (BPA) developed significantly worse insulin sensitivity within a four-day period, researchers found.

“We were surprised to see that reducing BPA exposure, such as using stainless steel or glass bottles and BPA-free cans, may lower diabetes risk,” said researcher Todd Hagobian, chair of kinesiology and public health at California Polytechnic State University.

For the study, researchers directly tested the “safe dose” for BPA set by the U.S. Food and Drug Administration, which is 50 micrograms for every kilogram of body weight.

BPA is used to make plastics for a range of consumer products like baby bottles, food containers, pitchers and tableware.

BPA is also known to disrupt hormone levels in humans, which can increase the risk of type 2 diabetes.

For decades, there have been concerns about the effects of BPA on humans. In 2012, the FDA banned the use of BPA in baby bottles and sippy cups over the effect the chemical might have on child development.

However, the FDA maintains that “the available information continues to support the safety of BPA for the currently approved uses in food containers and packaging,” according to the agency’s website.

In the study, the team recruited 40 healthy young adults and randomly assigned half of them to take oral BPA at the FDA’s safe level for four days, or a placebo.

Over the four days, body weight and blood sugar levels did not change significantly between the two groups.

However, the BPA group experienced a significant decrease in insulin sensitivity compared to the control group, results show.

“These results suggest that maybe the U.S. EPA safe dose should be reconsidered and that healthcare providers could suggest these changes to patients,” Hagobian said.

Researchers presented these findings Friday at the American Diabetes Association’s annual meeting in Orlando, Fla. Such research is considered preliminary until published in a peer-reviewed journal.

“With the increase in diabetes in the U.S., it is our duty to ensure safety within our products and in our homes,” Dr. Robert Gabbay, chief scientific and medical officer of the American Diabetes Association, said in a meeting news release. “This is only the beginning of highlighting the need for informed public health recommendations and policies.”

Researchers next plan to see if a lower BPA dose over several weeks or months increases diabetes risk. They also want to test whether aerobic exercise can reverse or overcome the negative effects of BPA.

Sources

  • American Diabetes Association, news release, June 21, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-06-26 23:15

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords